Lista de obras -

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia

artículo científico publicado en 2012

Angiogenic markers in pregnancies conceived through in vitro fertilization.

artículo científico publicado en 2015

Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia

artículo científico publicado en 2012

Circulating angiogenic factors and the risk of preeclampsia

artículo científico publicado en 2004

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia

artículo científico publicado en 2005

Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes

artículo científico publicado en 2007

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile

artículo científico publicado en 2013

Clinical risk factors for preeclampsia in the 21st century

artículo científico

Confocal light absorption and scattering spectroscopic microscopy monitors organelles in live cells with no exogenous labels

artículo científico publicado en 2007

Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy

artículo científico publicado en 2007

Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies

artículo científico publicado en 2010

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Infant size and the association between maternal circulating angiogenic factors and preeclampsia.

artículo científico publicado en 2018

Light-scattering spectroscopy differentiates fetal from adult nucleated red blood cells: may lead to noninvasive prenatal diagnosis

artículo científico

Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy ⬇️

artículo científico publicado el 10 de agosto de 2012

Maternal circulating angiogenic factors in twin and singleton pregnancies

artículo científico publicado en 2014

Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia

artículo científico publicado en 2012

Rupture of the posterior cul-de-sac during spontaneous labor.

artículo científico publicado en 2010

Soluble endoglin contributes to the pathogenesis of preeclampsia

artículo científico publicado en 2006

The Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia

artículo científico publicado en 2012

The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies.

artículo científico publicado en 2014

The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes

artículo científico publicado en 2013

The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome

artículo científico publicado en 2010

Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?

artículo científico publicado en 2008

Uric acid and preeclampsia

artículo científico publicado en 2005

Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia

artículo científico publicado en 2015

Lista de obras de

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia

Angiogenic markers in pregnancies conceived through in vitro fertilization.

Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia

Circulating angiogenic factors and the risk of preeclampsia

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia

Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile

Clinical risk factors for preeclampsia in the 21st century

Confocal light absorption and scattering spectroscopic microscopy monitors organelles in live cells with no exogenous labels

Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy

Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Infant size and the association between maternal circulating angiogenic factors and preeclampsia.

Light-scattering spectroscopy differentiates fetal from adult nucleated red blood cells: may lead to noninvasive prenatal diagnosis

Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy ⬇️

Maternal circulating angiogenic factors in twin and singleton pregnancies

Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia

Rupture of the posterior cul-de-sac during spontaneous labor.

Soluble endoglin contributes to the pathogenesis of preeclampsia

The Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia

The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies.

The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes

The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome

Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?

Uric acid and preeclampsia

Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia